Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Prescribing in patients with abnormal liver function tests.

Smith E, Desmond P.

Aust Fam Physician. 2013 Jan-Feb;42(1-2):30-3. Review.

2.

Laboratory evaluation of the patient with liver disease.

Astegiano M, Sapone N, Demarchi B, Rossetti S, Bonardi R, Rizzetto M.

Eur Rev Med Pharmacol Sci. 2004 Jan-Feb;8(1):3-9. Review.

PMID:
15209149
3.

The asymptomatic outpatient with abnormal liver function tests.

Krier M, Ahmed A.

Clin Liver Dis. 2009 May;13(2):167-77. doi: 10.1016/j.cld.2009.02.001.

PMID:
19442912
4.

Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.

Navaneethan U, Remzi FH, Nutter B, Fazio VW, Shen B.

Am J Gastroenterol. 2009 Oct;104(10):2467-75. doi: 10.1038/ajg.2009.343. Epub 2009 Jun 23.

PMID:
19550410
5.

Noninvasive assessment in vivo of hepatic drug metabolism in health and disease.

Vesell ES.

Ann N Y Acad Sci. 1984;428:293-307. Review.

PMID:
6378027
6.

Prescribing for older people with chronic renal impairment.

Bell JS, Blacker N, Leblanc VT, Alderman CP, Phillips A, Rowett D, Rossi S, Frank O, Husband A.

Aust Fam Physician. 2013 Jan-Feb;42(1-2):24-8. Review.

7.

Pharmacokinetics in liver disease.

Breimer DD.

Pharm Weekbl Sci. 1987 Apr 24;9(2):79-84. Review.

PMID:
3295764
8.

[Abnormal liver function tests in the primary care setting].

Vinker S, Nakar S, Nir E, Hyam E, Weingarten MA.

Harefuah. 1998 Aug;135(3-4):89-92, 168. Hebrew.

PMID:
9885647
9.

A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes.

Radcke S, Dillon JF, Murray AL.

Eur J Gastroenterol Hepatol. 2015 Jan;27(1):1-7. doi: 10.1097/MEG.0000000000000233. Review.

PMID:
25380394
10.

An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease.

Naranjo CA, Busto U, Janecek E, Ruiz I, Roach CA, Kaplan K.

Br J Clin Pharmacol. 1983 Apr;15(4):451-8.

11.

[Risk factors for abnormal liver function tests of parenteral nutrition in a referral hospital in Mexico].

Díaz de León González E, Gutiérrez Hermosillo H, Piquet Uscanga YO, García Vallejo C, Vázquez Martínez CA, Alvarado Zaldivar G, Tamez Pérez HE.

Nutr Hosp. 2011 Jul-Aug;26(4):729-36. doi: 10.1590/S0212-16112011000400010. Spanish.

12.

Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure.

Nikolaou M, Parissis J, Yilmaz MB, Seronde MF, Kivikko M, Laribi S, Paugam-Burtz C, Cai D, Pohjanjousi P, Laterre PF, Deye N, Poder P, Cohen-Solal A, Mebazaa A.

Eur Heart J. 2013 Mar;34(10):742-9. doi: 10.1093/eurheartj/ehs332. Epub 2012 Oct 22.

PMID:
23091203
13.

Non-invasive methods for the assessment of hepatic drug disposition.

Bircher J.

Int J Clin Pharmacol Res. 1983;3(6):415-9. Review.

PMID:
6432711
14.

Effects of liver disease on drug disposition in man.

Wilkinson GR, Schenker S.

Biochem Pharmacol. 1976 Dec 15;25(24):2675-81. Review. No abstract available.

PMID:
795432
15.

Serum glutathione S-transferase B1 activity as an index of liver function in cystic fibrosis.

Rattenbury JM, Taylor CJ, Heath PK, Howie AF, Beckett GJ.

J Clin Pathol. 1995 Aug;48(8):771-4.

16.
17.

Screening for liver disease - are LFTs old hat?

Lo R, Rye K, Austin A, Freeman J.

Curr Med Chem. 2009;16(12):1442-50. Review.

PMID:
19355898
18.

[Drug therapy in liver diseases: problems in intensive care].

Follath F.

Schweiz Med Wochenschr. 1986 Apr 26;116(17):549-52. German.

PMID:
3715434
19.

Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.

Abraham SC, Poterucha JJ, Rosen CB, Demetris AJ, Krasinskas AM.

Am J Surg Pathol. 2008 Jul;32(7):965-73. doi: 10.1097/PAS.0b013e3181622490.

PMID:
18460980
20.

Impairment of drug elimination in patients with liver disease.

Narang AP, Datta DV, Mathur VS.

Int J Clin Pharmacol Ther Toxicol. 1985 Jan;23(1):28-32.

PMID:
3988389

Supplemental Content

Support Center